Table 1.
Baseline characteristics of patients.
| Routine Test | FA-RP | p-Value | |||
|---|---|---|---|---|---|
| Period | I | II–III | II | III | |
| 2015.11.1–2016.6.30 | 2016.7.1–2018.7.31 | 2016.7.1–2017.6.30 | 2017.7.1–2018.7.31 | ||
| N | 321 | 594 | 264 | 330 | |
| Sex (Male %) | 179 (55.8) | 360 (60.6) | 158 (59.8) | 202 (61.2) | 0.344 |
| Age (years) | 3.5 ± 4.2 | 3.4 ± 4.2 | 3.3 ± 4.4 | 3.5 ± 4.1 | 0.454 |
| WBC (/µL) | 11,099 ± 5157 | 11,689 ± 5093 | 11,746 ± 5026 | 11,655 ± 5140 | 0.126 |
| Hb (g/dL) | 12.0 ± 1.1 | 12.2 ± 1.2 | 12.2 ± 1.2 | 12.2 ± 1.2 | 0.069 |
| Platelets (/µL) | 322,000 ± 124,000 | 358,000 ± 128,000 | 368,000 ± 116,000 | 353,000 ± 134,000 | 0.007 |
| CRP (mg/dL) | 2.2 ± 3.1 | 1.6 ± 2.2 | 2.0 ± 2.5 | 1.4 ± 2.0 | 0.051 |
| AST (IU/L) | 42 ± 34 | 44 ± 62 | 47 ± 95 | 42 ± 27 | 0.963 |
| ALT (IU/L) | 27 ± 48 | 31 ± 98 | 37 ± 151 | 27 ± 43 | 0.275 |
| LDH (IU/L) | 542 ± 134 | 582 ± 200 | 539 ± 160 | 602 ± 214 | 0.009 |
p-values were calculated between periods I (2015.11.1–2016.6.30) and II–III (2016.7.1–2018.7.31).